CoChat

CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens

Open access
Ishii, Tsuyoshi, Okai, Takuro, Iwatani-Yoshihara, Misa, Mochizuki, Manabu, Unno, Satoko, Kuno, Masako, Yoshikawa, Masato, Shibata, Sachio, Nakakariya, Masanori, Yogo, Takatoshi, Kawamoto, Tomohiro · 2017 · Scientific Reports
Cited by 48

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The proof of target engagement (TE) is a key element for evaluating potential investment in drug development. The cellular thermal shift assay (CETSA) is expected to facilitate direct measurement of intracellular TE at all stages of drug development. However, there have been no reports of applying this technology to comprehensive animal and clinical studies. This report demonstrates that CETSA can not only quantitatively evaluate the drug-TE in mouse peripheral blood, but also confirm TE in animal tissues exemplified by using the receptor interacting protein 1 kinase (RIPK1) lead compound we have developed. Our established semi-automated system allows evaluation of the structure-activity relationship using native RIPK1 in culture cell lines, and also enables estimation of drug occupancy ratio in mouse peripheral blood mononuclear cells. Moreover, optimized tissue homogenisation enables monitoring of the in vivo drug-TE in spleen and brain. Our results indicate that CETSA methodology will provide an efficient tool for preclinical and clinical drug development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-12513-1

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 48

Metadata

Authors
Ishii, T., Okai, T., Iwatani-Yoshihara, M., Mochizuki, M., Unno, S., Kuno, M., Yoshikawa, M., Shibata, S., Nakakariya, M., Yogo, T., & Kawamoto, T.
Venue
Scientific Reports
Published
2017-10-12
Volume
7
Issue
1
Pages
13000-13000
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2762422564
Cited by
48
References
10
FWCI
2.14
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens. https://app.cochat.ai/papers/10.1038/s41598-017-12513-1
The paper
Ishii, T., Okai, T., Iwatani-Yoshihara, M., Mochizuki, M., Unno, S., Kuno, M., Yoshikawa, M., Shibata, S., Nakakariya, M., Yogo, T., & Kawamoto, T. (2017). CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens. Scientific Reports. https://doi.org/10.1038/s41598-017-12513-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.